Perbedaan Habco Trans Maritima Tbk. dan Organon Pharma Indonesia Tbk.: Habco Trans Maritima Tbk. diperdagangkan di Rp595 (kapitalisasi pasar 5,59 T, volume 24 jam 7,27 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Habco Trans Maritima Tbk. jauh lebih besar — sekitar 53,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HATM | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 5,59 T | 104,4 M |
Volume | 7,27 jt | — |
Lot | 72,74 rb | — |
Perputaran | 4,29 M | — |
Harga Rata-rata | 589,75 | — |
Nilai Transaksi | 4,29 M | — |
Harga Ekuilibrium Indikatif | 595 | — |
Volume Ekuilibrium Indikatif | 319 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Habco Trans Maritima Tbk (the “Company”) was established based on Notarial Deed No. 10 of Tito Utoyo, S.H., dated August 8, 2019, notary in Pekanbaru.
Selengkapnya di halaman HATM →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →